Menu
Create an Account
Log in
Home
Activities
Courses and Conferences
HIV In-Person and Virtual Courses
Earn CME From On-Demand Webcasts
The 2022 Ryan White HIV/AIDS Program CLINICAL CONFERENCE
Conference on Retroviruses and Opportunistic Infections
About IAS–USA Courses
Webinars
Upcoming Webinars
2022 On-Demand Webinars
Earn CME From On-Demand Webinars
About Webinars
COVID-19 Dialogue Series
Upcoming Dialogues
On-Demand Dialogues
Topics in Antiviral Medicine
Current Issues
Previous Issues
TAM
Policies and Practices
Resources
Guidelines
HIV Drug Resistance Mutations
Podcasts
On-Demand Webcasts
Slides
Research Collaboration
Useful Resources for COVID-19 Information and Guidance
Practice Question of the Week
Fellow/Student Resources
Other Resources
About
Mission
IAS–USA Scientific Leadership Board
IAS–USA Governance
Core Faculty
Staff
CME
Funding Information
Careers
Donate
Website Policies
FAQs
Contact
Topics in Antiviral Medicine
™
June/July 2022
Volume 30, Issue 3
Invited Reviews
CROI 2022: Tuberculosis and Infectious Complications in Persons With HIV
Andrew D. Kerkhoff, MD, PhD, MSc, Diane V. Havlir, MD
CROI 2022: Metabolic and Other Complications of HIV Infection or COVID-19
Sudipa Sarkar, MD;, Todd T. Brown, MD, PhD
Preventing and Diagnosing HIV-Related Comorbidities in Adolescents
Hasiya Eihuri Yusuf, MD, MPH, David Griffith, MD, Allison Lorna Agwu, MD, ScM
Topics in Antiviral Medicine™
Current Issues
Previous Issues
TAM
Policies and Practices
TAM
Author and Contributor Guidelines
Topics in Antiviral Medicine
Editorial Board
Home
Activities
Courses and Conferences
HIV In-Person and Virtual Courses
Earn CME From On-Demand Webcasts
The 2022 Ryan White HIV/AIDS Program CLINICAL CONFERENCE
Conference on Retroviruses and Opportunistic Infections
About IAS–USA Courses
Webinars
Upcoming Webinars
2022 On-Demand Webinars
Earn CME From On-Demand Webinars
About Webinars
COVID-19 Dialogue Series
Upcoming Dialogues
On-Demand Dialogues
Topics in Antiviral Medicine
Current Issues
Previous Issues
TAM
Policies and Practices
Resources
Guidelines
HIV Drug Resistance Mutations
Podcasts
On-Demand Webcasts
Slides
Research Collaboration
Useful Resources for COVID-19 Information and Guidance
Practice Question of the Week
Fellow/Student Resources
Other Resources
About
Mission
IAS–USA Scientific Leadership Board
IAS–USA Governance
Core Faculty
Staff
CME
Funding Information
Careers
Donate
Website Policies
FAQs
Contact
Practice Question of the Week
June 20, 2022: Antiretroviral Therapy During Conception and Pregnancy
Which of the following antiretroviral therapy (ART) regimens is now recommended for all pregnancy-related clinical categories for people with HIV (PWH)?
A. Bictegravir/tenofovir alafenamide/emtricitabine
B. Doravirine/tenofovir disoproxil fumarate/lamivudine
C. Dolutegravir/tenofovir alafenamide/emtricitabine
D. Cabotegravir/rilpivirine
E. Dolutegravir/lamivudine
Watch Presentation
View Related Resources
Leave Feedback
Subscribe
CLOSE